Literature DB >> 2968440

Immunohistochemical study of Alzheimer's disease using antibodies to synthetic amyloid and fibronectin.

F Koike1, T Kunishita, H Nakayama, T Tabira.   

Abstract

Etiology and source of amyloid deposition in senile plaques of Alzheimer's disease (AD) are still unknown. In order to know whether or not fibronectin (Fn), an adhesive glycoprotein, is related to the amyloid deposition in the senile plaque, we conducted immunohistochemical studies using polyclonal anti-Fn and affinity-purified anti-amyloid component (Affi 28). Affi 28 was made by immunizing a rabbit against the synthetic peptide corresponding to residues 1-28 of the amyloid core protein reported by Masters et al. (1985). According to this study, four points became clear. First, Affi 28 is able to stain the subpial regions of AD as well as cerebrovascular amyloid and amyloid plaque cores. Second, it is suggested either that the etiology and source of neurofibrillary tangles and Pick body is distinct from that of the senile plaque or that any Affi 28 determinants of neurofibrillary tangles and Pick body are obscured sterically. Third, Affi 28 is useful to distinguish the senile plaque from the amyloid plaque of Creutzfeldt-Jakob disease. Last, there is no association between the amyloid in the senile plaque and Fn, at least immunohistochemically. The absence of Fn in the senile plaque suggests that Fn may not be requested for the deposition of amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968440     DOI: 10.1016/0022-510x(88)90031-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments.

Authors:  R Doi-Yi; T Kitamoto; J Tateishi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

3.  An immunohistochemical study of beta-protein in Alzheimer-type dementia brains.

Authors:  H Arai; N Sagi; I Noguchi; S Haga; T Ishii; Y Makino; K Kosaka
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

4.  Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy.

Authors:  D H Chui; T Tabira; S Izumi; G Koya; J Ogata
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

5.  Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease.

Authors:  P Eikelenboom; S S Zhan; W Kamphorst; P van der Valk; J M Rozemuller
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 6.  The Role of Basement Membranes in Cerebral Amyloid Angiopathy.

Authors:  Matthew D Howe; Louise D McCullough; Akihiko Urayama
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.